Flash Finance
Market closed12 Nov close Nifty 5025,299.35+0.18% Sensex81,911.01+0.04% Bank Nifty61,518.50+1.19% Midcap 15022,760.75+0.72% Smallcap 25017,994.50+1.10% Nifty IT32,163.55-0.41% India VIX16.61-5.38%
Follow Flash Finance FollowTelegram

Sahajanand Medical Technologies LimitedSMTCorporate

Medical Equipment & Supplies Latest results: Sep 2026 2 quarters of data
Consolidated Standalone
₹504.65
MCap ₹5,130 Cr
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹373 Cr
Sales · Sep 2026
₹66 Cr
Operating Profit · Sep 2026
17.6%
OPM % · Sep 2026
₹26 Cr
Net Profit · Sep 2026
₹2.63
EPS · Sep 2026

📝 Sahajanand Medical Technologies Limited — results explained

Quarter ended September 2026 (Q2 FY27)

Sahajanand Medical Technologies Limited reported revenue of ₹373 crore for the quarter ended September 2026 (Q2 FY27), and up 6.2% sequentially over the June 2026 quarter.

Net profit stood at ₹26 crore. Earnings per share (EPS) came in at ₹2.63.

Operating profit stood at ₹66 crore — an operating margin (OPM) of 17.6%.

Valuation snapshot

At the current price of ₹504.65, SMT has a market capitalisation of ₹5,130 crore.

Within the Medical Equipment & Supplies industry, it is the largest of the 14 companies we track by market value.

Related 🏭 Healthcare sector

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹5,130 Cr
Current Price ?
₹504.6
P/E ?
N/A
Industry P/E ?
27.30
P/B ?
6.96
P/S ?
N/A
P/FCF ?
N/A
Enterprise Value ?
₹5,461 Cr
EV/EBITDA ?
N/A
PEG ?
N/A
Earnings Yield ?
N/A
Dividend Yield ?
N/A
Profitability & Returns
Sales (TTM) ?
N/A
OPM ?
N/A
Profit after tax (TTM) ?
N/A
EPS (TTM) ?
N/A
ROCE ?
N/A
ROE ?
N/A
ROA ?
N/A
Growth
Sales — latest qtr ?
₹373 Cr
PAT — latest qtr ?
₹26 Cr
YoY qtr sales growth ?
N/A
YoY qtr profit growth ?
N/A
Sales growth (3y) ?
N/A
Sales growth (5y) ?
N/A
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
₹332 Cr
Debt to Equity ?
0.45
Interest Coverage ?
N/A
Ownership
Promoter holding ?
N/A
Change in promoter holding ?
N/A
FII holding ?
N/A
DII holding ?
N/A
Market
Return 3 months ?
33.6%
Return 6 months ?
33.6%

🗓️ Quarterly results (2 quarters · ₹ Cr)

same fiscal quarter as Sep bestweakest per row · for costs (interest, NPAs) low is best
Metric Jun 2026Sep 2026 YoY % QoQ %
Sales 352373 — +6.2%
Operating Profit 4966 — +34.9%
Other Income 32 — -16.1%
Interest 77 — +4.1%
Depreciation 2021 — +2.4%
Profit Before Tax 2440 — +65.0%
Net Profit 1526 — +75.4%
EPS 1.482.63 — +77.7%
OPM % 13.8% 17.6% — +27.5%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 1 periods)

Metric Sep 2026 % Chg
Equity Capital 10 —
Reserves 727 —
Borrowings 332 —
Other Liabilities 257 —
Total Liabilities 1,326 —
Fixed Assets 338 —
CWIP 15 —
Investments 63 —
Other Assets 909 —
Total Assets 1,326 —

📦 Working Capital (latest 1 periods)

Metric Sep 2026 % Chg
Inventories 330 —
Trade Receivables 318 —
Trade Payables 103 —

⚖️ Peer comparison

Industry: Medical Equipment & Supplies · 14 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% ROE% ROCE% D/E Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 SMT Sahajanand Medical ₹502.00 5,103 — — — — — — — 0.45 — — — —
2 FISCHER Fischer Medical ₹33.50 2,293 85.2 367 24 12.3% 6.7% — — — 178.6% 2051.4% 249.4% -24.3%
3 TARSONS Tarsons Products ₹330.00 1,756 234.0 463 7 26.6% 1.6% 1.2% 5.0% 0.63 -66.3% -81.4% 20.8% -110.4%
4 DENTALKART Vasa Denticity ₹563.10 977 79.8 312 12 4.6% 3.9% 6.3% 9.0% 0.00 16.7% -28.5% 18.3% 4.2%
5 543916 Hemant Surgical ₹193.85 544 13.9 231 18 10.4% 7.8% — — — — — 187.9% 160.0%
6 543363 Prevest Denpro ₹616.50 456 32.8 75 23 35.7% 29.9% — — — 13.6% 17.6% 23.7% 24.8%
7 QMSMEDI QMS Medical ₹185.89 359 52.7 162 7 13.1% 4.1% 12.2% 13.0% 0.65 5.1% -47.9% 23.7% -0.8%
8 NURECA Nureca ₹301.60 302 60.4 174 5 3.5% 2.7% 2.5% 3.0% 0.04 34.0% 146.7% 55.1% 11.6%
9 530427 Choksi Asia ₹65.64 119 7.2 47 5 14.5% 11.1% — — — 61.1% 173.2% -22.5% -10.1%
10 527005 Shree Pacetronix ₹168.25 55 19.2 21 3 24.8% 15.3% — — — 28.7% 324.3% -8.3% 14.5%
11 544143 Royal Sense ₹139.00 44 24.7 38 3 12.8% 8.0% — — — — — 2.5% -5.4%
12 533212 GKB Ophthalmics ₹104.90 35 17.6 150 6 7.0% 3.7% — — — 36.8% 142.7% 2.3% 388.5%
13 531380 Centenial Surgical ₹110.90 27 — 56 -1 10.7% -2.6% — — — 0.6% -38.1% 18.6% 1937.8%
14 542765 Transpact Enterprises ₹325.00 4 140.1 0 0 63.2% 47.4% — — — — — 12.5% -20.0%
❓ Frequently asked questions
What was Sahajanand Medical Technologies Limited's revenue in Q2 FY27?
Sahajanand Medical Technologies Limited reported revenue of ₹373 crore for the quarter ended September 2026 (Q2 FY27), and up 6.2% sequentially over the June 2026 quarter.
What was Sahajanand Medical Technologies Limited's net profit in Q2 FY27?
Net profit stood at ₹26 crore. Earnings per share (EPS) came in at ₹2.63.
What is SMT's market capitalisation and P/E ratio?
At the current price of ₹504.65, SMT has a market capitalisation of ₹5,130 crore.
TTM ends N/A. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI